NYSEAMERICAN:CCEL Cryo-Cell International (CCEL) Stock Price, News & Analysis $4.16 -0.08 (-1.89%) Closing price 09/28/2026 04:10 PM EasternExtended Trading$4.20 +0.04 (+0.84%) As of 09/28/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsInsider TradesNews and TrendsOwnershipSEC Filings About Cryo-Cell International Stock (NYSEAMERICAN:CCEL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CCEL alerts:Sign Up Key Stats Today's Range$4.15▼$4.1650-Day Range$3.30▼$4.5652-Week Range$2.72▼$4.90Volume1,907 shsAverage Volume13,700 shsMarket Capitalization$33.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Cryo-Cell International, Inc. is a biotechnology and healthcare services company focused on the collection, processing, testing and long-term storage of umbilical cord blood and cord tissue. The company provides families with access to private stem cell banking services intended to preserve potentially valuable biological material for future medical use. Its services generally include coordinating the collection of cord blood and tissue at birth, transporting specimens to its processing facilities, isolating and cryopreserving stem cells, and maintaining the stored materials under controlled conditions. Cryo-Cell also offers related enrollment, storage-management and customer-support services for families that choose to bank their newborn’s cord-derived cells. Founded in 1989, Cryo-Cell is headquartered in Oldsmar, Florida. The company serves customers in the United States and has pursued international business through partnerships and distribution or licensing relationships. Its operations are centered on private cord blood and tissue banking rather than the development or sale of pharmaceutical products.AI Generated. May Contain Errors. Read More Cryo-Cell International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreCCEL MarketRank™: Cryo-Cell International scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingCryo-Cell International has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageCryo-Cell International has received no research coverage in the past 90 days.Read more about Cryo-Cell International's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cryo-Cell International is -13.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cryo-Cell International is -13.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.18% of the float of Cryo-Cell International has been sold short.Short Interest Ratio / Days to CoverCryo-Cell International has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cryo-Cell International has recently increased by 60.03%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCryo-Cell International does not currently pay a dividend.Dividend GrowthCryo-Cell International does not have a long track record of dividend growth. News and Social Media0.9 / 5News SentimentN/A News SentimentCryo-Cell International has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cryo-Cell International this week, compared to 0 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cryo-Cell International insiders have not sold or bought any company stock.Percentage Held by Insiders38.59% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions10.44% of the stock of Cryo-Cell International is held by institutions.Read more about Cryo-Cell International's insider trading history. Receive CCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CCEL Stock News HeadlinesCryo-Cell International (NYSEAMERICAN:CCEL) Stock Price Crosses Above Fifty Day Moving Average - Time to Sell?September 22, 2026 | americanbankingnews.comDer aktuelle Kurs der CryoCell International Inc Aktie beträgt 3,5700.August 6, 2026 | de.investing.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.September 29 at 1:00 AM | Banyan Hill Publishing (Ad)Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial ResultsJuly 15, 2026 | businesswire.comCryo-Cell Receives Acceptance of Compliance Plan From NYSE AmericanMay 8, 2026 | businesswire.comCryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood BanksApril 28, 2026 | finance.yahoo.comWall Street Analysts Are Neutral on Top Healthcare PicksApril 19, 2026 | theglobeandmail.comCryo-Cell International receives NYSE American notice over listing non-complianceMarch 13, 2026 | msn.comSee More Headlines CCEL Stock Analysis - Frequently Asked Questions How have CCEL shares performed this year? Cryo-Cell International's stock was trading at $3.44 at the start of the year. Since then, CCEL stock has increased by 20.9% and is now trading at $4.16. How were Cryo-Cell International's earnings last quarter? Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) posted its quarterly earnings data on Wednesday, July, 15th. The company reported $0.07 earnings per share (EPS) for the quarter. The company had revenue of $7.78 million for the quarter. How do I buy shares of Cryo-Cell International? Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cryo-Cell International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cryo-Cell International investors own include Meta Platforms (META), Alimera Sciences (ALIM), Crescent Biopharma (CBIO), NVIDIA (NVDA), Aspen Group (ASPU). Company Calendar Last Earnings7/15/2026Today9/29/2026Fiscal Year End11/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 CCEL's financial health is in the Green zone, according to TradeSmith. CCEL has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSEAMERICAN:CCEL CIK862692 Webwww.cryo-cell.com Phone(813) 749-2104Fax813-855-4745Employees76Year Founded1989Profitability EPS (Trailing Twelve Months)($1.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.43 million Net Margins-7.92% Pretax Margin-8.18% Return on EquityN/A Return on Assets-4.00% Debt Debt-to-Equity RatioN/A Current Ratio0.71 Quick Ratio0.69 Sales & Book Value Annual Sales$31.57 million Price / Sales1.06 Cash FlowN/A Price / Cash FlowN/A Book Value($2.31) per share Price / Book-1.80Miscellaneous Outstanding Shares8,060,000Free Float4,951,000Market Cap$33.53 million OptionableNot Optionable Beta0.47 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSEAMERICAN:CCEL) was last updated on 9/29/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryo-Cell International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryo-Cell International With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
